# Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis

> **NCT03315611** · NA · COMPLETED · sponsor: **Fraunhofer-Institute of Toxicology and Experimental Medicine** · enrollment: 23 (actual)

## Conditions studied

- Atopic Dermatitis
- Allergy Pollen

## Interventions

- **DRUG:** 'Eucerin AtopiControl Lotion' (for the body)
- **OTHER:** Allergen challenge chamber

## Key facts

- **NCT ID:** NCT03315611
- **Lead sponsor:** Fraunhofer-Institute of Toxicology and Experimental Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-02
- **Primary completion:** 2018-04-25
- **Final completion:** 2018-04-25
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2018-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03315611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03315611, "Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03315611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*